![Laurence A. Rubin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Laurence A. Rubin
Directeur Général chez Ellipsis Neurotherapeutics, Inc.
Postes actifs de Laurence A. Rubin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ellipsis Neurotherapeutics, Inc.
![]() Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada. | Directeur Général | 01/11/2004 | - |
Weizmann Canada
![]() Weizmann Canada Miscellaneous Commercial ServicesCommercial Services Weizmann Canada operates as a worldwide network of supporting organizations for the Weizmann Institute of Science. The company was founded in 1964 and is headquartered in Calgary, Canada. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Laurence A. Rubin
Anciens postes connus de Laurence A. Rubin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ellipsis Biotherapeutics Corp.
![]() Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | President | - | - |
University of Toronto | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Canada | 5 |
Opérationnelle
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
President | 1 |
Sectorielle
Commercial Services | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Ellipsis Neurotherapeutics, Inc.
![]() Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada. | Health Technology |
Ellipsis Biotherapeutics Corp.
![]() Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
Weizmann Canada
![]() Weizmann Canada Miscellaneous Commercial ServicesCommercial Services Weizmann Canada operates as a worldwide network of supporting organizations for the Weizmann Institute of Science. The company was founded in 1964 and is headquartered in Calgary, Canada. | Commercial Services |
- Bourse
- Insiders
- Laurence A. Rubin
- Expérience